Triangular titanium implants for minimally invasive sacroiliac joint fusion: 2-year follow-up from a prospective multicenter trial

Keyphrases

• 2-year Follow-up 100%
• Sacroiliac Joint 100%
• Triangular Titanium Implant 100%
• Prospective multicenter Trial 100%
• Minimally Invasive Sacroiliac Joint Fusion 100%
• Sacroiliac Joint Pain 75%
• Minimally Invasive 50%
• Quality of Life 50%
• Short Form 36 (SF-36) 50%
• Oswestry Disability Index 50%
• Sacroiliac Joint Dysfunction 50%
• EuroQol 50%
• SI Joint Fusion 50%
• Change from Baseline 50%
• Intra-articular 25%
• Adverse Events 25%
• Computed Tomography 25%
• Device-independent 25%
• Visual Analog Scale 25%
• Low Back Pain 25%
• High-resolution 25%
• Patient Satisfaction 25%
• Surgical Treatment 25%
• Bone Growth 25%
• Titanium Implant 25%
• Opioids 25%
• Iliac 25%
• Multicenter Clinical Trial 25%
• Structured Assessment 25%
• Bone Apposition 25%
• Pain-related Disability 25%
• Pain Scale 25%
• Sacroiliac Joint Fusion 25%
• Pelvic CT 25%
• Joint Surgery 25%
• Prospective multicenter 25%
• Subject Age 25%
• Radiographic Evidence 25%
• Related Adverse Events 25%
• Pain Level 25%
• Mid-term Outcomes 25%
• SIJ Dysfunction 25%

Medicine and Dentistry

• Sacroiliac Joint 100%
• Titanium Implant 100%
• Sacroiliac Joint Fusion 100%
• Arthralgia 33%
• Implant 22%
• Quality of Life 22%
• Arthrodesis 22%
• Oswestry Disability Index 22%
• Short Form 36 22%
• X-Ray Computed Tomography 22%
• Adverse Event 22%
• Clinical Trial 11%
• Pelvis 11%
• Bone Growth 11%
• Visual Analog Scale 11%
• Patient Satisfaction 11%
• Low Back Pain 11%
• Operation on Joint 11%
• Surgery 11%